Metronidazole Benzoate (Tillotts Pharma)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMetronidazole Benzoate (Tillotts Pharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA synthesis inhibitors
TargetsUpdating
Therapy Area/Indications +[1N/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTillotts Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTillotts Pharma Ag
Active IndicationsN/A
Inactive Indications +[1N/A

Other Information

ATC CodeN/A
Related LinksN/A